It has been previously established that KIF11 is associated with adverse outcomes in various diseases, such as gallbladder and pancreatic cancer, primarily due to its ability to modulate cell proliferation and vitality (Wei et al., 2021; Gu et al., 2022; Zhu et al., 2023). Here, KIF11 is linked to pancreatic neoplasm.